HOVON HO115 SCT
                Gearchiveerd                
            
            Main info
- Identificatie:
 - HOVON 115 double UBCT
 - Sponsor:
 - HOVON
 - Working group party:
 - SCT & Supportive care
 - Age:
 - 18-70
 - Stadium:
 - 1st lijn
 - Echelon:
 - Level A
 - Included patients:
 - 
                                        70(of 70)
 - Active sites:
 - 
                                                            7(of 7)
 - Title:
 Double umbilical cord blood transplantation in high-risk hematological patients. A phase II study focusing on the mechanism of graft predominance
Timeline
Scheduled
                Actual
            2012
                        31 jan.
                            Opportunity
                        2012
                        10 jul.
                            Activated
                        2012
                        10 jul.
                            EC Approval
                        2012
                        20 aug.
                            First Site
                        2012
                        22 aug.
                            FPI
                        2015
                        18 jun.
                            ClosedForInclusionActualStart
                        2020
                        28 jan.
                            Closeout in Progress
                        2020
                        18 jun.
                            Closeout in Progress
                        2021
                        30 mrt.
                            Archived
                        Flow
        Details
- Phase:
 - Prospective Phase II study
 - Monitoring Type:
 - Not any more
 - Objectives:
 - To study the presence of an alloreactive immune response of CD4+ T-cells of the predominant CBU, directed against the non-engrafting CBU as a causative mechanism in CBU predominance.
 - To assess engraftment and engraftment kinetics;
 - to evaluate immune reconstitution, acute and chronic GVHD, chimerism, toxicity, progression-free survival and overall survival after double unit UCBT.
 
Eligibility
- Inclusion Criteria:
 - Age 18-70 years inclusive
 - Diagnosis of poor-risk hematological malignancy or (V)SAA relapsing after or failing immunosuppressive therapy and meeting the criteria for a MUD allo SCT
 - Lacking a sufficiently matched volunteer unrelated donor or lacking such a donor within the required time period of ≤ 2 months in case of
 
urgently needed alloSCT
- Availability of 2 (≥4/6) matched UCB grafts with a total nuclear cell count > 4 x 107/kg (see paragraph 8.2).
 - WHO performance status 0-2
 - Written informed consent
 
- Exclusion Criteria:
 - Bilirubin and/or transaminases > 2.5 x normal value
 - Creatinine clearance < 40 ml/min
 - Cardiac dysfunction as defined by:
- Reduced left ventricular function with an ejection fraction < 45% as measured by MUGA scan or echocardiogram (another method for measuring cardiac function is acceptable)
 - Unstable angina
 - Unstable cardiac arrhythmias
 
 - Pulmonary function test with VC, FEV1 and/ or DCO < 50%
 - Active, uncontrolled infection
 - History of high dose (≥ 8 Gy) total body irradiation
 - Pregnant or lactating females
 - HIV positivity
 
Registration Details
Eligible patients should be registered before start of treatment. Patients need to be registered at the HOVON Data Center by one of the following options:
- By ALEA; Use goto eCRF button > select the [Patient tab] and click the [Add new patient] button. Complete all items and click the [Submit] button
 - By faxing the completed registration/randomization CRF +31 (0)10 704 1028 Monday through Friday, from 09:00 to 17:00 CET
 - By phone +31 (0)10 704 1560 Monday through Friday, from 09:00 to 17:00 CET
 
Participating Sites
Ziekenhuizen die deelnemen aan het onderzoek staan benoemd op de HOVON website bij het onderzoek. Het kan zijn dat uw ziekenhuis niet genoemd wordt, maar wel aan het onderzoek deelneemt. Informeer hiernaar bij uw arts.
Site
                7 results
                    Order by
                    Accrual rate
                        Activation date
                    NL-Rotterdam-EMCDANIEL
                        32
                        10 sep. 2012
                                                                            
                        
                    NL-Utrecht-UMCUTRECHT
                        16
                        21 aug. 2013
                                                                            
                        
                    NL-Amsterdam-VUMC
                        8
                        03 jan. 2013
                                                                            
                        
                    NL-Amsterdam-AMC
                        7
                        22 aug. 2012
                                                                            
                        
                    NL-Leiden-LUMC
                        5
                        01 okt. 2012
                                                                            
                        
                    NL-Nijmegen-RADBOUDUMC
                        2
                        20 aug. 2012
                                                                            
                        
                    NL-Maastricht-MUMC